N-(1,7-diphenylheptan-4-yl)-3-[4-(2-hydroxy-3-quinolin-5-yloxypropyl)piperazin-1-yl]-3-oxopropanamide

C38H46N4O4 — CID 20622404

IUPACN-(1,7-diphenylheptan-4-yl)-3-[4-(2-hydroxy-3-quinolin-5-yloxypropyl)piperazin-1-yl]-3-oxopropanamide
SMILESO=C(CC(=O)N1CCN(CC(O)COc2cccc3ncccc23)CC1)NC(CCCc1ccccc1)CCCc1ccccc1
InChIInChI=1S/C38H46N4O4/c43-33(29-46-36-21-9-20-35-34(36)19-10-22-39-35)28-41-23-25-42(26-24-41)38(45)27-37(44)40-32(17-7-15-30-11-3-1-4-12-30)18-8-16-31-13-5-2-6-14-31/h1-6,9-14,19-22,32-33,43H,7-8,15-18,23-29H2,(H,40,44)
InChIKeyLCPLGNLDEOTYOQ-UHFFFAOYSA-N
MW622.81 g/mol
LogP5.04
Rot. Bonds16

About N-(1,7-diphenylheptan-4-yl)-3-[4-(2-hydroxy-3-quinolin-5-yloxypropyl)piperazin-1-yl]-3-oxopropanamide

N-(1,7-diphenylheptan-4-yl)-3-[4-(2-hydroxy-3-quinolin-5-yloxypropyl)piperazin-1-yl]-3-oxopropanamide (PubChem CID 20622404) has the molecular formula C38H46N4O4 and a molecular weight of 622.81 g/mol. Its IUPAC name is N-(1,7-diphenylheptan-4-yl)-3-[4-(2-hydroxy-3-quinolin-5-yloxypropyl)piperazin-1-yl]-3-oxopropanamide.

Molecular Properties

Compound NameN-(1,7-diphenylheptan-4-yl)-3-[4-(2-hydroxy-3-quinolin-5-yloxypropyl)piperazin-1-yl]-3-oxopropanamide
PubChem CID20622404
Molecular FormulaC38H46N4O4
Molecular Weight622.81 g/mol
Exact Mass622.35
IUPAC NameN-(1,7-diphenylheptan-4-yl)-3-[4-(2-hydroxy-3-quinolin-5-yloxypropyl)piperazin-1-yl]-3-oxopropanamide
SMILESO=C(CC(=O)N1CCN(CC(O)COc2cccc3ncccc23)CC1)NC(CCCc1ccccc1)CCCc1ccccc1
InChIInChI=1S/C38H46N4O4/c43-33(29-46-36-21-9-20-35-34(36)19-10-22-39-35)28-41-23-25-42(26-24-41)38(45)27-37(44)40-32(17-7-15-30-11-3-1-4-12-30)18-8-16-31-13-5-2-6-14-31/h1-6,9-14,19-22,32-33,43H,7-8,15-18,23-29H2,(H,40,44)
InChIKeyLCPLGNLDEOTYOQ-UHFFFAOYSA-N
XLogP5.04
TPSA95.00 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds16
Heavy Atoms46
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500622.81
LogP ≤ 55.04
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}

Analyze N-(1,7-diphenylheptan-4-yl)-3-[4-(2-hydroxy-3-quinolin-5-yloxypropyl)piperazin-1-yl]-3-oxopropanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(1,7-diphenylheptan-4-yl)-3-[4-(2-hydroxy-3-quinolin-5-yloxypropyl)piperazin-1-yl]-3-oxopropanamide?
The IUPAC name of N-(1,7-diphenylheptan-4-yl)-3-[4-(2-hydroxy-3-quinolin-5-yloxypropyl)piperazin-1-yl]-3-oxopropanamide (CID 20622404) is N-(1,7-diphenylheptan-4-yl)-3-[4-(2-hydroxy-3-quinolin-5-yloxypropyl)piperazin-1-yl]-3-oxopropanamide.
What is the SMILES notation for N-(1,7-diphenylheptan-4-yl)-3-[4-(2-hydroxy-3-quinolin-5-yloxypropyl)piperazin-1-yl]-3-oxopropanamide?
The canonical SMILES for N-(1,7-diphenylheptan-4-yl)-3-[4-(2-hydroxy-3-quinolin-5-yloxypropyl)piperazin-1-yl]-3-oxopropanamide is O=C(CC(=O)N1CCN(CC(O)COc2cccc3ncccc23)CC1)NC(CCCc1ccccc1)CCCc1ccccc1.
What is the InChIKey of N-(1,7-diphenylheptan-4-yl)-3-[4-(2-hydroxy-3-quinolin-5-yloxypropyl)piperazin-1-yl]-3-oxopropanamide?
The InChIKey is LCPLGNLDEOTYOQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C38H46N4O4/c43-33(29-46-36-21-9-20-35-34(36)19-10-22-39-35)28-41-23-25-42(26-24-41)38(45)27-37(44)40-32(17-7-15-30-11-3-1-4-12-30)18-8-16-31-13-5-2-6-14-31/h1-6,9-14,19-22,32-33,43H,7-8,15-18,23-29H2,(H,40,44).
What are the key properties of N-(1,7-diphenylheptan-4-yl)-3-[4-(2-hydroxy-3-quinolin-5-yloxypropyl)piperazin-1-yl]-3-oxopropanamide?
N-(1,7-diphenylheptan-4-yl)-3-[4-(2-hydroxy-3-quinolin-5-yloxypropyl)piperazin-1-yl]-3-oxopropanamide has a molecular weight of 622.81 g/mol, XLogP of 5.04, 16 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-(1,7-diphenylheptan-4-yl)-3-[4-(2-hydroxy-3-quinolin-5-yloxypropyl)piperazin-1-yl]-3-oxopropanamide is sourced from PubChem (CID 20622404), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).